BBR not only augmented TRAIL-induced apoptosis in the TRAIL-sensitive MDA-MB-231 breast cancer cells, but also sensitized the TRAIL-resistant MDA-MB-468 breast cancer cells to TRAIL-induced apoptosis. This evidence concerns the gene TNFSF10 and breast carcinoma.